Sysmex Inostics GmbH to Collaborate with Merck KGaA to Develop and Commercialize a Blood-Based RAS Biomarker Test for Patients with Metastatic Colorectal Cancer
Our DNA blood tests provide precise insight into the genetics of solid tumors. This is accomplished with our highly sensitive BEAMing Digital PCR and sequencing technologies. With a liquid biopsy, treatment decisions can now be made with the right information at any time. Non-invasive. Sensitive. Real-time.
SENSITIVE MUTATION DETECTION
OncoBEAM – Single Gene Testing
OncoBEAM – Multigene Testing